Hip Osteoarthritis
A practical guide to non-surgical regenerative options for hip osteoarthritis, including PRP and stem cell therapy, and how Dr. Bhandari approaches each case in Bellevue, WA.
What Is Hip Osteoarthritis?
Hip osteoarthritis is a chronic degenerative condition of the deep ball-and-socket joint where the femoral head sits in the acetabulum. Hip osteoarthritis pain often shows up in the groin or on the outside of the upper thigh, while the earliest sign of degenerative changes is loss of internal rotation. At Dr. Bhandari's Bellevue practice, it is treated with non-surgical regenerative options aimed at preserving the joint.
What sets hip OA apart is how much the surrounding structures contribute to the condition. The acetabular labrum, the cartilage rim that seals the socket and centers the femoral head, often degenerates and speeds cartilage wear once it loses its integrity, while the thick capsule stiffens and range of motion is lost early. In many patients the root cause is femoroacetabular impingement, a subtle mismatch in the shape of the ball or socket that pinches the labrum and cartilage for years before pain begins.
Because the joint sits deep in the pelvis, it rarely hurts where the damage is. Pain centers in the groin and can refer to the buttock, outer thigh, or knee, so hip arthritis is often mistaken for a back or knee problem. Trouble with shoes and socks, a shortening stride, and a developing limp round out the picture. For patients weighing their options before hip replacement, Dr. Bhandari focuses on the joint and the structures around it.
What Are the Standard Conventional Treatments for Hip Osteoarthritis?
Standard care for hip osteoarthritis runs from activity modification and physical therapy to anti-inflammatories and image-guided steroid injection, ending at total hip replacement. What sets the hip apart is that even a routine cortisone shot must be delivered under ultrasound or fluoroscopy, because the joint is far too deep to reach by feel.
Physical therapy and load management remain a sensible foundation. Considering the deep hip joint anatomy, any injection here needs imaging to land accurately in the joint, so a quick in-office shot placed by palpation is not appropriate. When injections stop helping, the endpoint is total hip replacement: removing the femoral head and resurfacing the socket, replacing the native joint. Rehabilitation can often run longer than a comparable knee recovery, though outcomes are comparable and in my experience, generally better than knee replacements. Many patients reasonably want to exhaust joint-preserving options first.
Why Do Conventional Treatments Often Fall Short?
The deeper issue with standard hip care is that it manages symptoms while the joint keeps degenerating, and the hip's anatomy adds problems other joints do not face. For patients who want to keep their own joint, this is where Dr. Bhandari's regenerative approach is aimed.
A cortisone injection placed by feel lands inconsistently, so blind injections give variable and often disappointing results, and beyond accuracy, repeated intra-articular steroid has been linked to faster cartilage loss. The joint also lies close to the femoral nerve and vessels, so precise needle placement is also a safety requirement. And while hip replacement is effective for end-stage disease, it doesn't reliably resolve the pain and doesn't last forever, so delaying or preventing surgery is often preferable.
Standard care also stops at the joint surface. Dr. Bhandari's integrative naturopathic framework looks instead for the metabolic, inflammatory, and biomechanical drivers pushing the degeneration forward, the work that begins with a comprehensive pain management assessment.
Can PRP Help with Hip Osteoarthritis?
Platelet-rich plasma (PRP) therapy places a concentrated dose of the patient's own growth factors directly inside the hip joint, where it may calm the inflamed synovium and improve the environment around the femoral head and acetabular cartilage. Because the hip is deep and bordered by major vessels, accurate delivery depends on imaging, so Dr. Bhandari injects under real-time ultrasound guidance.
What PRP Does for Hip OA Specifically
In the hip, the targets include femoroacetabular cartilage, the inflamed synovial lining, the degenerating acetabular labrum, and the ligamentous joint capsule. PRP introduces its growth-factor signal to shift that environment away from active breakdown towards a regenerative one; this mechanism is covered in more depth on the PRP service page. Because a dense muscle envelope and thick capsule wrap the joint, the injectate must reach the correct compartment to act on the labrum and cartilage at all. PRP will not reliably heal a structurally torn labrum, but it can ease the secondary inflammation that labrum tears generate, while stabilizing the tissue.
Patients who respond tend to describe it functionally: an easier stride, less pain on stairs and getting out of a car, more comfortable rotation pulling on shoes, and sleeping on that side again. These gains build over two to six months and are most realistic in mild to moderate disease, with less consistent results seen in severe osteoarthritis.
Research Evidence
A randomized clinical trial in Joints (Doria et al., 2017) compared ultrasound-guided intra-articular PRP with hyaluronic acid in early hip osteoarthritis; both improved significantly from baseline in pain and function at six and twelve months, marking PRP as a viable option with sustained benefit. A systematic review in the Journal of Ultrasonography (Ali et al., 2018) likewise found PRP injections for hip osteoarthritis safe and associated with better pain and function. The evidence base for use of PRP in hip OA is smaller than that for knee OA and is still growing, so Dr. Bhandari sets expectations from the current literature for each case.
Dr. Bhandari's Approach to PRP for Hip OA
The joint sits beneath layers of muscle and close to the femoral neurovascular bundle, so it cannot be reached reliably or safely by palpation alone. Dr. Bhandari performs every hip injection under real-time ultrasound guidance, confirming the needle in the joint space on-screen before releasing anything. Each PRP dosage is also lab-verified and dosed to the individual's needs, and this process is further detailed on the PRP service page.
Does Stem Cell Therapy Work for Hip Osteoarthritis?
For advanced hip osteoarthritis, autologous adipose-derived stem cell therapy offers a much stronger regenerative signal, providing the best available regenerative orthobiologic treatment for hip osteoarthritis. When PRP is no longer likely to provide an adequate regenerative signal, adipose-derived stem cells can help with addressing the degeneration of the cartilage, labrum, and joint capsule. Dr. Bhandari delivers this cellular preparation into the deep hip joint under ultrasound guidance.
What Adipose-Derived Stem Cell Therapy Does for Hip OA
Advanced hip OA is rarely confined to the cartilage surface. By late stage OA, the labrum, capsule, and subchondral bone are typically involved together. A cellular preparation contributes a much stronger, sustained regenerative signal with cellular and structural components, suiting the level of damage better than PRP. This is further detailed on the stem cell service page. Similar to PRP, all regenerative injections for the hip need to be image-guided for maximal confidence of correct placement; the MFAT preparation needs to be placed directly into the joint or target tissue to be optimally effective in producing a desirable outcome.
Where it helps, patients report the same functional gains PRP responders describe, though typically with longer lasting benefits. With very advanced hip osteoarthritis, the capacity for regeneration can become quite limited, so often the realistic goal becomes increased comfort and function, for as long as possible.
Research Evidence
A longitudinal study in Regenerative Therapy (Hatano et al., 2025) followed patients given intra-articular autologous adipose-derived stem cells for hip OA and reported gains in pain and function over time. A retrospective study in Advances in Orthopedics (Braile et al., 2025) documented meaningful symptom improvement after a single such injection. The hip evidence is still emerging and more limited than for the knee, but clinically Dr. Bhandari has seen consistent results with this therapy.
Dr. Bhandari's Approach to Stem Cell Therapy for Hip OA
Dr. Bhandari uses only autologous adipose-derived cellular therapy, cells taken from the patient's own fat and injected back on the same day. He does not use donor-derived "stem cells in a vial" products, which are most often mislabeled growth-factor concentrates rather than true cell preparations. The harvest and MFAT processing are described further on the stem cell therapy page.
When Are Multiple Therapies Combined for Hip Osteoarthritis?
Hip pain rarely comes from the cartilage alone, and treatment plans at Dr. Bhandari's Bellevue clinic are built around that. PRP and stem cell therapy work inside the joint to address cartilage, but the labrum, tendons and bursae over the greater trochanter, and the systemic inflammatory or metabolic load, are often treated concurrently.
When greater trochanteric pain and gluteal tendinopathy present with the joint disease, or the periarticular tendons and ligaments that stabilize the hip are involved, extracorporeal shockwave therapy or prolotherapy may be added to treat those structures alongside the intra-articular work.
When sensitized nerves add a burning or diffuse quality to groin or lateral hip pain that structural treatment does not fully settle, perineural injection therapy (PIT) may be included as well.
Ready to Explore Non-Surgical Treatment for Your Hip?
Schedule a consultation with Dr. Bhandari to review your case, imaging, and history and to determine whether PRP, stem cell therapy, or a combined approach is the right fit for your hip.
Frequently Asked Questions
Cortisone calms an inflamed hip for a few weeks by suppressing the local inflammatory response, but repeated intra-articular steroid has been linked to faster cartilage loss, and in a joint this deep it still has to be placed under imaging to land accurately. PRP delivers a concentrated dose of the patient's own growth factors into the joint to prompt an active healing response that may improve the cartilage and synovial environment around the femoral head. The aim is to help the joint repair itself.
For hip osteoarthritis, many patients see meaningful improvement after one to three treatments, though the right number depends on how much cartilage and labral wear is present, how the load-bearing joint is responding, and the result of the first injection. Dr. Bhandari decides this from a thorough assessment of your imaging and history, and reviews a realistic plan with you during the consultation.
PRP works by starting a healing response, so improvement in a hip builds gradually. Most patients first notice easier walking and weight-bearing within four to eight weeks, with continued gains in stride and rotation comfort through the three-to-six-month window, when benefit usually peaks. Dr. Bhandari sets realistic, case-specific expectations at the initial consultation.
PRP is generally the starting point for mild to moderate hip osteoarthritis. Adipose-derived stem cell therapy is the stronger option, considered when wear is more advanced and the cartilage, labrum, and capsule are involved together, when PRP alone has not done enough, or when a patient wants the most robust regenerative signal available. Its diverse cell population gives it a wider biological reach than PRP, which matters in a joint where damage is rarely confined to one tissue. Dr. Bhandari makes the call from examination, imaging, and case history.
For hip osteoarthritis, Dr. Bhandari uses only the patient's own adipose tissue, harvested and injected the same day. He does not use donor-derived "stem cells in a vial" products, which are most often mislabeled growth-factor concentrates rather than true cell preparations. An autologous adipose graft contains several cell types, growth factors, and signaling molecules that an umbilical or embryonic commercial product cannot replicate.
Assessment starts with your history, a hands-on hip exam, and review of imaging, usually weight-bearing X-rays and often an MRI to gauge the cartilage and labrum. Because groin and hip pain can come from the joint itself, the labrum, the surrounding tendons and bursae, or be referred from the lower back, Dr. Bhandari works to pin down which structure is actually generating the pain before recommending anything. He also weighs metabolic and inflammatory contributors and the mechanics loading the joint, and orders lab work as part of the workup.
Dr. Ashok Bhandari treats hip osteoarthritis at SageMED in Bellevue, WA. He is one of the few providers in the Greater Seattle area to combine lab-verified PRP dosing, highly concentrated and individualized PRP preparations, real-time ultrasound-guided injection delivery into the deep hip joint, and an integrative whole-person assessment for hip osteoarthritis.
To schedule a consultation or ask a question about your specific case, contact the clinic here.
Dr. Ashok Bhandari treats hip osteoarthritis with autologous adipose-derived stem cell therapy at SageMED in Bellevue, WA. He is one of the few providers in the Greater Seattle area to offer a same-day, in-office adipose harvest processed into MFAT and delivered into the hip joint under real-time ultrasound guidance, using only the patient's own tissue rather than a donor-derived commercial product.
To schedule a consultation or ask a question about your specific case, contact the clinic here.